Studies have shown that 40% of SLE patients possess titers of anti-NMDA receptor antibody against NR2A/NR2B subunits of NMDAR in the serum and they are the reason for the cognitive decline. The gene discussed is GRIN2A; the disease is systemic lupus erythematosus.